3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Conditions
Lung Neoplasms
12
Carcinoma, Non-Small-Cell Lung
7
Parkinson Disease 4, Autosomal Dominant Lewy Body
2
Delirium
2
Thromboembolism
1
Small Cell Lung Carcinoma
1
Respiratory Insufficiency
1
Postoperative Complications
1
Pneumonia
1
Pleural Effusion, Malignant
1
Pleural Effusion
1
Neurotoxicity Syndromes
1
Neoplasms
1
Myocardial Infarction
1
Metastatic Non-Squamous Non-Small Cell Lung Cancer
1
Mesothelioma
1
Lung Diseases
1
Inoperable Stage III Non-small Cell Lung Cancer
1
Emergence Delirium
1
Arrhythmias, Cardiac
1
Angina, Unstable
1
Agnosia
1
Acute Coronary Syndrome
1
Interventions
Cisplatin
8
Carboplatin
8
Bevacizumab
8
Pleurodesis
7
Talc
6
Paclitaxel
6
Docetaxel
5
Povidone-Iodine
4
Doxycycline
4
Thoracoscopy
3
Taxes
3
Gemcitabine
3
Drug Therapy
3
Chest Tubes
3
aldesleukin
2
Zoledronic Acid
2
Trastuzumab
2
Thoracentesis
2
Surveys and Questionnaires
2
Sodium Chloride
2
Silver Nitrate
2
Pharmaceutical Preparations
2
Nivolumab
2
Magnetic Resonance Spectroscopy
2
Interleukin-2
2
High-Energy Shock Waves
2
Fluorodeoxyglucose F18
2
Fentanyl
2
Erlotinib Hydrochloride
2
Cetuximab
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Pleural Effusion, Malignant
×
Saline Solution
×
Thoracic
×
Clear all
NCT01411202
2020-09-25
OPUS
Ottawa Hospital Research Institute
Phase 2
Unknown
40 enrolled